8-K filed Jun 02, 2025 23:59 UTC ticker SLP CIK 0001023459

other_material confidence high sentiment neutral materiality 0.65

Simulations Plus appoints new CRO, restructures workforce; cuts 23 jobs (~10%), expects $4.3M annual savings

Simulations Plus, Inc.

John DiBella appointed Chief Revenue Officer; Daniel Szot departs at end of fiscal Q3 for other opportunities.
Other leadership changes: Will Frederick named EVP/CFO, Josh Fohey becomes COO; several divisional role adjustments.
Workforce reduction of ~23 employees (10% of full-time staff) to improve operational efficiency.
Estimated $0.7M severance charges in FY2025; expects $4.3M annualized operating expense reduction.
No changes to employment agreements or compensation for appointees; no familial relationships disclosed.

item 5.02item 2.05item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Erik Guffrey

Co-Chief Product and Technology Officer

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Erik Guffrey , currently Chief Technology Officer, Adaptive Learning & Insights and Medical Communications Products, assumes the new role of Co-Chief Product and Technology Officer.

Role change

Dr. Jonathan Chauvin

Co-Chief Product and Technology Officer

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Dr. Jonathan Chauvin , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Co-Chief Product and Technology Officer.

Role change

Josh Fohey

Chief Operating Officer

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Josh Fohey , currently Senior Vice President, Operations, assumes the new role of Chief Operating Officer.

Appointed

John DiBella

Chief Revenue Officer

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

On May 30, 2025 (the “Effective Date”), the Board of Directors (the “Board”) of Simulations Plus, Inc. (the “Company”) appointed John DiBella as Chief Revenue Officer of the Company, effective immediately.

Role change

Steven Chang

Global Head of Strategic Alliances

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Steven Chang , currently Business Unit President, Quantitative Systems Pharmacology Solutions, assumes the new role of Global Head of Strategic Alliances.

Role change (interim)

Jill Fiedler-Kelly

Interim President, Services Solutions

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Jill Fiedler-Kelly , currently Business Unit Co-President, Clinical Pharmacology & Pharmacometric Solutions, assumes the new role of Interim President, Services Solutions.

Role change

Will Frederick

Executive Vice President and Chief Financial Officer

SLP · Simulations Plus, Inc.

Effective: 2025-05-30
Filed: Jun 02, 2025 23:59 UTC

Will Frederick , currently Chief Financial Officer and Chief Operating Officer, assumes the new role of Executive Vice President and Chief Financial Officer.

Departed

Daniel Szot

Chief Revenue Officer

SLP · Simulations Plus, Inc.

Successor: John DiBella
Filed: Jun 02, 2025 23:59 UTC

On the Effective Date, the Company and Daniel Szot, the Company’s Chief Revenue Officer, mutually agreed to Mr. Szot’s separation from the Company, to take effect at the end of the third fiscal quarter which allows for smooth transition as Mr. Szot seeks to pursue other opportunities.

Source: SEC EDGAR

accession 0001023459-25-000035

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.